Nuvation Financial Statements From 2010 to 2024

NUVB Stock  USD 2.89  0.09  3.21%   
Nuvation Bio financial statements provide useful quarterly and yearly information to potential Nuvation Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nuvation Bio financial statements helps investors assess Nuvation Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nuvation Bio's valuation are summarized below:
Market Capitalization
972.7 M
Enterprise Value Revenue
201.0797
Revenue
2.2 M
Earnings Share
(2.18)
Revenue Per Share
0.009
We have found one hundred twenty available fundamental ratios for Nuvation Bio, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Nuvation Bio last-minute market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Nuvation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvation Bio's main balance sheet or income statement drivers, such as Interest Expense of 11.1 M, Depreciation And Amortization of 261.8 K or Selling General Administrative of 22.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.57. Nuvation financial statements analysis is a perfect complement when working with Nuvation Bio Valuation or Volatility modules.
  
Check out the analysis of Nuvation Bio Correlation against competitors.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.

Nuvation Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities10 M14 M4.8 M
Slightly volatile
Accounts Payable2.3 M2.2 MM
Slightly volatile
Total Current Assets439.4 M616.4 M189.1 M
Slightly volatile
Total Assets530.8 M621.5 M268.8 M
Slightly volatile
Other Current Liabilities7.2 M7.7 M3.4 M
Slightly volatile
Total Stockholder Equity514.6 M605.1 M260.9 M
Slightly volatile
Property Plant And Equipment Net3.1 M4.3 M1.5 M
Slightly volatile
Cash68.1 M42.6 M27.2 M
Slightly volatile
Non Current Assets Total3.5 MMM
Slightly volatile
Non Currrent Assets Other691.6 K728 K37.7 M
Slightly volatile
Cash And Short Term Investments521.9 M611.2 M264.3 M
Slightly volatile
Net Receivables2.5 M3.7 M1.4 M
Slightly volatile
Common Stock Shares Outstanding206.3 M218.9 M200.3 M
Pretty Stable
Short Term Investments453.8 M568.6 M237 M
Slightly volatile
Liabilities And Stockholders Equity530.8 M621.5 M268.8 M
Slightly volatile
Other Current Assets1.4 M1.5 M1.6 M
Slightly volatile
Total Liabilities16.2 M16.4 M7.9 M
Slightly volatile
Common Stock678.6 M947.7 M256.7 M
Slightly volatile
Property Plant Equipment1.6 MM956.4 K
Slightly volatile
Other Liabilities928.6 K977.5 KM
Slightly volatile
Warrants91.4 M102.9 M112 M
Slightly volatile
Common Stock Total Equity724.1 M1.1 B342.5 M
Slightly volatile
Non Current Liabilities Total3.9 M2.4 M1.7 M
Slightly volatile
Capital Surpluse18.6 M20.9 M22.8 M
Slightly volatile
Inventory776.5 M739.5 M189 M
Slightly volatile
Net Invested Capital590.8 M605.1 M277.4 M
Slightly volatile
Property Plant And Equipment GrossMM1.8 M
Slightly volatile
Capital Stock845.6 M947.7 M454.3 M
Slightly volatile
Non Current Liabilities Other3.3 M3.5 M18.4 M
Slightly volatile
Short and Long Term Debt Total4.2 MM3.3 M
Slightly volatile
Short Term DebtM3.9 MM
Slightly volatile

Nuvation Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization261.8 K222 K104.6 K
Slightly volatile
Selling General Administrative22.1 M26.8 M12.1 M
Slightly volatile
Selling And Marketing Expenses2.1 MM466.6 K
Slightly volatile
Other Operating Expenses85.5 M99.8 M50.9 M
Slightly volatile
Research Development62.9 M71.3 M38.3 M
Slightly volatile
Total Operating Expenses85.5 M99.8 M50.9 M
Slightly volatile
Net Interest Income25.8 M24.6 M5.5 M
Slightly volatile
Interest Income25.8 M24.6 M5.6 M
Slightly volatile
Cost Of Revenue323.7 K222 K168.7 K
Slightly volatile
Reconciled Depreciation194.7 K222 K128.8 K
Slightly volatile
Non Operating Income Net Other12.2 M17.9 M8.3 M
Slightly volatile

Nuvation Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings8.4 M16.5 MM
Slightly volatile
Depreciation134.6 K222 K64.8 K
Slightly volatile
Capital Expenditures65.5 K69 K501.4 K
Slightly volatile
Total Cash From Financing Activities596.6 K628 K60.8 M
Slightly volatile
End Period Cash Flow56.7 M42.6 M24.5 M
Slightly volatile
Change To Netincome8.6 M8.5 M7.8 M
Pretty Stable
Begin Period Cash Flow58.7 M101.1 M21.8 M
Slightly volatile
Sale Purchase Of Stock802.8 K845.1 K99.7 M
Slightly volatile
Stock Based Compensation13 M19.5 M5.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.3 M1.9 M1.3 M
Slightly volatile
Capex To Depreciation0.30.310834.1556
Slightly volatile
Inventory Turnover0.02820.03170.0345
Slightly volatile
Days Of Inventory On Hand8.3 K9.3 K10.2 K
Slightly volatile
Payables Turnover0.0960.10050.0692
Slightly volatile
Cash Per Share1.662.79250.9449
Slightly volatile
Days Payables Outstanding4.6 K3.6 K6.6 K
Slightly volatile
Income Quality0.650.89710.6966
Slightly volatile
Net Debt To EBITDA0.550.3880.3308
Slightly volatile
Current Ratio28.2344.112916.0897
Slightly volatile
Graham Number2.94.64141.6694
Slightly volatile
Capex Per Share3.0E-43.0E-40.0025
Slightly volatile
Interest Debt Per Share0.00530.0090.0066
Slightly volatile
Debt To Assets0.0030.00322.2792
Slightly volatile
Days Of Payables Outstanding4.6 K3.6 K6.6 K
Slightly volatile
Ebt Per Ebit1.00.75940.998
Slightly volatile
Effective Tax Rate0.07540.130.0672
Slightly volatile
Quick Ratio28.1744.112916.0559
Slightly volatile
Net Income Per E B T1.00.980.9452
Very volatile
Cash Ratio3.253.0521.9206
Slightly volatile
Days Of Inventory Outstanding8.3 K9.3 K10.2 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.0011.0262
Very volatile
Debt Ratio0.0030.00322.2792
Slightly volatile

Nuvation Fundamental Market Drivers

Cash And Short Term Investments611.2 M

Nuvation Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Nuvation Bio Financial Statements

Nuvation Bio stakeholders use historical fundamental indicators, such as Nuvation Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nuvation Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nuvation Bio's assets and liabilities are reflected in the revenues and expenses on Nuvation Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nuvation Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue222 K323.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:
Check out the analysis of Nuvation Bio Correlation against competitors.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.18)
Revenue Per Share
0.009
Return On Assets
(0.14)
Return On Equity
(0.96)
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.